Last updated on August 2013

New Options for Alzheimer's Research


Brief description of study

New Options for Alzheimer's Research

Detailed Study Description

MD Clinical is conductiong a 26-week, placebo-controlled research study of the safety & efficacy of an investigational drug for Alzheimer's Disease. Study-related exams & study drugs are provided at no cost. Qualified participants & caregivers will be compensated for time & travel.

Clinical Study Identifier: TX137166

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.